Pre-Transplant blood test may flag BK virus danger

NCT ID NCT04506060

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at 378 kidney transplant patients to see if measuring antibodies against BK virus before transplant could predict whether the virus would reactivate after surgery. Researchers used a lab-made virus-like particle to test for five different BK virus types. The goal is to help doctors identify high-risk patients and prevent kidney damage from BK virus infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors identify kidney transplant patients at higher risk for BK virus reactivation, allowing closer monitoring and earlier intervention.

What could go wrong

This is an observational study, not a treatment trial. It only measures antibodies before transplant and does not test any new drug or therapy. The results may not lead to changes in care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

BK-virus nephropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens

    Amiens, 80480, France